Back
NovaBay Pharmaceuticals Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
0.72
Seasonality Move:
-18.64%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.5 | Buy |
| 50-day SMA: | 0.83 | Sell |
| 200-day SMA: | 3.74 | Sell |
| 8-day EMA: | 0.55 | Buy |
| 20-day EMA: | 0.55 | Buy |
| 50-day EMA: | 0.94 | Sell |
| 200-day EMA: | 8.27 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 61.79 | Buy |
| Chaikin Money Flow: | -53331864 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.45 - 0.57) | Buy |
| Bollinger Bands (100): | (0.56 - 3.36) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.74 while NBY 8-day simple moving average is 0.52, which is a Buy signal.
- The stock price of NBY is 0.74 while NovaBay Pharmaceuticals 20-day SMA is 0.50, which makes it a Buy.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.83 while NBY share price is 0.74, making it a Sell technically.
- NBY stock price is 0.74 and NovaBay Pharmaceuticals 200-day simple moving average is 3.74, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.62M
Price in USD:
0.74
Share Volume:
144.66M
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
17.74
52-Week Low:
0.36
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.74 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.74 while NBY 8-day exponential moving average is 0.55, which is a Buy signal.
- The stock price of NBY is 0.74 while NovaBay Pharmaceuticals 20-day EMA is 0.55, which makes it a Buy.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.94 while NBY share price is 0.74, making it a Sell technically.
- NBY stock price is 0.74 and NovaBay Pharmaceuticals 200-day simple moving average is 8.27, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting NovaBay Pharmaceuticals is a Sell
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 61.79, which suggest NovaBay Pharmaceuticals is overbought
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.45 - 0.57), which suggest NovaBay Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.56 - 3.36), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.